HPV (human papillomavirus) is a leading cause of several types of head and neck cancers, particularly those affecting the oropharynx. The understanding of HPV’s role in cancer pathogenesis has led to new diagnostic and therapeutic approaches, significantly impacting prevention, treatment, and patient outcomes. This session will explore the latest research, prevention strategies, and advancements in treatment and management for HPV-related head and neck cancers.
Track 11:1 Epidemiology and Risk Factors
Track 11:2 Diagnosis and Screening
Track 11:3 Treatment Modalities
Track 11:4 Vaccination and Prevention Strategies
Track 11:5 Survivorship and Quality of Life
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
